pubmed-article:7515413 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:7515413 | lifeskim:mentions | umls-concept:C0015967 | lld:lifeskim |
pubmed-article:7515413 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:7515413 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:7515413 | lifeskim:mentions | umls-concept:C0684249 | lld:lifeskim |
pubmed-article:7515413 | lifeskim:mentions | umls-concept:C0079459 | lld:lifeskim |
pubmed-article:7515413 | lifeskim:mentions | umls-concept:C1521750 | lld:lifeskim |
pubmed-article:7515413 | lifeskim:mentions | umls-concept:C0021149 | lld:lifeskim |
pubmed-article:7515413 | lifeskim:mentions | umls-concept:C0220812 | lld:lifeskim |
pubmed-article:7515413 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
pubmed-article:7515413 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:7515413 | pubmed:dateCreated | 1994-7-1 | lld:pubmed |
pubmed-article:7515413 | pubmed:abstractText | We sought to determine the incidence of neutropenic fever associated with the use of standard-dose combination chemotherapy for small-cell lung cancer (SCLC) and to use these data as a template to analyze the costs and benefits of the routine use of granulocyte colony-stimulating factor (G-CSF). | lld:pubmed |
pubmed-article:7515413 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7515413 | pubmed:language | eng | lld:pubmed |
pubmed-article:7515413 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7515413 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:7515413 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7515413 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:7515413 | pubmed:month | Jun | lld:pubmed |
pubmed-article:7515413 | pubmed:issn | 0732-183X | lld:pubmed |
pubmed-article:7515413 | pubmed:author | pubmed-author:EinhornL HLH | lld:pubmed |
pubmed-article:7515413 | pubmed:author | pubmed-author:WilliamsS DSD | lld:pubmed |
pubmed-article:7515413 | pubmed:author | pubmed-author:NicholsC RCR | lld:pubmed |
pubmed-article:7515413 | pubmed:author | pubmed-author:KuoS LSL | lld:pubmed |
pubmed-article:7515413 | pubmed:author | pubmed-author:RothB JBJ | lld:pubmed |
pubmed-article:7515413 | pubmed:author | pubmed-author:LoehrerP JPJ | lld:pubmed |
pubmed-article:7515413 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:7515413 | pubmed:volume | 12 | lld:pubmed |
pubmed-article:7515413 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:7515413 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:7515413 | pubmed:pagination | 1245-50 | lld:pubmed |
pubmed-article:7515413 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:7515413 | pubmed:meshHeading | pubmed-meshheading:7515413-... | lld:pubmed |
pubmed-article:7515413 | pubmed:meshHeading | pubmed-meshheading:7515413-... | lld:pubmed |
pubmed-article:7515413 | pubmed:meshHeading | pubmed-meshheading:7515413-... | lld:pubmed |
pubmed-article:7515413 | pubmed:meshHeading | pubmed-meshheading:7515413-... | lld:pubmed |
pubmed-article:7515413 | pubmed:meshHeading | pubmed-meshheading:7515413-... | lld:pubmed |
pubmed-article:7515413 | pubmed:meshHeading | pubmed-meshheading:7515413-... | lld:pubmed |
pubmed-article:7515413 | pubmed:meshHeading | pubmed-meshheading:7515413-... | lld:pubmed |
pubmed-article:7515413 | pubmed:meshHeading | pubmed-meshheading:7515413-... | lld:pubmed |
pubmed-article:7515413 | pubmed:meshHeading | pubmed-meshheading:7515413-... | lld:pubmed |
pubmed-article:7515413 | pubmed:meshHeading | pubmed-meshheading:7515413-... | lld:pubmed |
pubmed-article:7515413 | pubmed:meshHeading | pubmed-meshheading:7515413-... | lld:pubmed |
pubmed-article:7515413 | pubmed:meshHeading | pubmed-meshheading:7515413-... | lld:pubmed |
pubmed-article:7515413 | pubmed:meshHeading | pubmed-meshheading:7515413-... | lld:pubmed |
pubmed-article:7515413 | pubmed:year | 1994 | lld:pubmed |
pubmed-article:7515413 | pubmed:articleTitle | Incidence of neutropenic fever in patients treated with standard-dose combination chemotherapy for small-cell lung cancer and the cost impact of treatment with granulocyte colony-stimulating factor. | lld:pubmed |
pubmed-article:7515413 | pubmed:affiliation | Department of Medicine, Indiana University School of Medicine, Indianapolis. | lld:pubmed |
pubmed-article:7515413 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:7515413 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7515413 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7515413 | lld:pubmed |